PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23477782-0	2014	Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3beta.	3- ethoxycarbonyl-1-aza-9-oxafluorenes	64-102	cyclin dependent kinase 1	Homo sapiens	190-194
23477782-0	2014	Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3beta.	3- ethoxycarbonyl-1-aza-9-oxafluorenes	64-102	cyclin dependent kinase 5	Homo sapiens	196-200
23477782-0	2014	Approaches to a multitargeting drug development: first profiled 3- ethoxycarbonyl-1-aza-9-oxafluorenes representing a perspective compound class targeting Alzheimer disease relevant kinases CDK1, CDK5 and GSK-3beta.	3- ethoxycarbonyl-1-aza-9-oxafluorenes	64-102	glycogen synthase kinase 3 alpha	Homo sapiens	205-214